Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of retinol-binding protein 4 are found in people with alopecia areata, but these levels don't relate to how severe the condition is.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Baricitinib shows promise for treating alopecia areata with mild side effects.

ANE syndrome is caused by a mutation in the RBM28 protein that disrupts ribosome assembly.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

A new gene mutation causes vitamin D-resistant rickets and hair loss in two siblings.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Early and accurate diagnosis is crucial for managing rare genetic disorders like this localized variant of junctional epidermolysis bullosa.

A genetic variant in the GJB6 gene likely caused the Labrador's paw pad condition.

New RIPK4 gene mutations were found to cause a type of skin and limb birth defect.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Ruxolitinib treatment may cause eyelash growth.

The mutant HR bmh protein mis-localizes in cells, affecting skin and hair development.

A rabbit gene important for hair development was identified and detailed.

The Paxbp1 gene is crucial for healthy hair follicles.

Jumonji genes are important for development and their mutations can cause abnormalities, especially in the heart and brain.

Rumex japonicus Houtt. may be an effective treatment for atopic dermatitis by reducing inflammation.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

The 736T>A mutation in the LIPH gene is common in Japanese people with autosomal recessive woolly hair.

The Japan Society of Clinical Hair Restoration (JSCHR) focuses on improving hair restoration techniques in Japan.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

JAK inhibitors show promise for treating various skin diseases.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Janus kinase inhibitors may help treat lichen planopilaris.